Stockreport

The Edwards Lifesciences Dilemma Persists: Strong Growth Potential, High Price [Seeking Alpha]

Edwards Lifesciences Corporation  (EW) 
Last edwards lifesciences corporation earnings: 4/23 04:15 pm Check Earnings Report
US:NYSE Investor Relations: ir.edwards.com
PDF EW's TAVR business has reaccelerated from early in 2025, supported by new clinical data and guideline changes, and TMTT could double revenue share by 2030. Competitiv [Read more]